Parkman Healthcare Partners’s Inspire Medical Systems INSP Stock Holding History

Parkman Healthcare Partners’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,000	Closed	-$1.38M	–	101
2025 Q4	$1.38M	Buy	+15,000	New	+$1.44M	0.13%	89
2024 Q2	–	Sell	-81,183	Closed	-$17.4M	–	100
2024 Q1	$17.4M	Sell	81,183 -22,563	-22%	-$4.42M	2.14%	12
2023 Q4	$21.1M	Buy	103,746 +76,823	+285%	+$12.4M	2.97%	7
2023 Q3	$5.34M	Buy	26,923 +12,453	+86%	+$3.14M	0.98%	34
2023 Q2	$4.7M	Buy	+14,470	New	+$4.13M	0.81%	37
2020 Q2	–	Sell	-20,000	Closed	-$1.21M	–	81
2020 Q1	$1.21M	Sell	20,000 -4,750	-19%	-$352K	0.56%	50
2019 Q4	$1.84M	Buy	+24,750	New	+$1.59M	0.53%	53

Other funds holding INSP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Parkman Healthcare Partners's INSP Position: Q1 2026 in Review

Parkman Healthcare Partners sold out of Inspire Medical Systems (INSP) in Q1 2026, closing a stake of 15,000 shares — an estimated $1.38M sold.

Parkman Healthcare Partners first reported a position in INSP in Q4 2019 and held it in 7 quarters. The position peaked at $21.1M in Q4 2023. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

Parkman Healthcare Partners reported no remaining Inspire Medical Systems position as of Q1 2026 after selling out during the quarter.
Parkman Healthcare Partners sold 15,000 Inspire Medical Systems shares in Q1 2026, an estimated $1.38M.
Parkman Healthcare Partners first reported a position in Inspire Medical Systems in Q4 2019 and held it in 7 quarters.
Parkman Healthcare Partners's Inspire Medical Systems position peaked at $21.1M in Q4 2023.
301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.